Alexander Rebchuk (@AlexRebchuk) header
Alexander Rebchuk (@AlexRebchuk) profile picture

Neurosurgeon | @BarrowNeuro Neuroendovascular Fellow | @UBC Research Associate | 🧠🇨🇦

Phoenix, Arizona
Joined May 2020
Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)Photo by Alexander Rebchuk (@AlexRebchuk)
Great to publish our local case series on the safety of early discharge and abbreviated nimodipine course in aSAH in @_jocn sciencedirect.com/science/ar…
1
83
Our recent study in @_jocn found similar rates of ruptured cerebral aneurysm treatment within 24h in British Columbia for rural and urban patients using a hub and spoke model of care. jocn-journal.com/article/S09… #BC #neurosurgery #VRAD
1
108
Congrats Dr Sekhon and team at UBC on their landmark discovery of the physiology of dying in @NatureMedicine nature.com/articles/s41591-0…
1
153
Alexander Rebchuk retweeted
In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability compared to medical management alone. ja.ma/3VtSrUo
1
41
4
139
33,375
Great read in @TheJNS about Dr. Takanori Fukushima. Fascinating career and an inspiration to all neurosurgeons. doi.org/10.3171/2025.4.JNS25…
2
213
Excited to share our operative video of kissing vertebral arteries causing myelopathy treated with bilateral MVD using a sling technique. Just published in @NeurosurgeryCNS #Nsgy journals.lww.com/onsonline/a…
3
226
Alexander Rebchuk retweeted
pleased to be awarded a 2025 @NSERC_CRSNG Discovery grant, providing support for our deep brain stimulation research program langresearchlab.ca
3
1
29
1,141
#MolecularAlterations of grade 3 #meningiomas stratify clinical outcomes more so than histologic features alone - this was one of the key findings from a recent investigation published by ICOM members. Read full article and findings in @EditorNeuro here: buff.ly/41eUKOX
1
5
402
This article evaluates the overall survival (OS) and local recurrence (LR) in patients with grade 2 #meningiomas treated with adjuvant #radiotherapy compared to surgery alone at time of diagnosis. Read more about their research: buff.ly/3ZUe43k @Sty_md
2
8
622
Alexander Rebchuk retweeted
An article discussing development and validation of a molecular classifier of meningiomas is now available in Neuro-Oncology. 👉 academic.oup.com/neuro-oncol… #EANOessentials #NeuroOncology #Meningioma
8
2
27
4,593
Alexander Rebchuk retweeted
#STROKE Images: Chemotherapy, thrombocytopenia, disseminated intravascular coagulation and sepsis can trigger sudden, multi-focal intracerebral hemorrhage in the setting of leukemia. @AlexRebchuk @UBCmedicine #AHAJournals ahajrnls.org/3ZUlW3q
1
18
1
49
3,578
There is hope for patients living with Parkinson’s disease. Dr. Stefan Lang is undertaking research on treating non-motor symptoms of Parkinson’s, hoping to overcome the emotional and cognitive challenges faced by these patients. @StefanLang_MD @VCHResearch
2
4
17
1,134
Just published an interesting case report in @StrokeAHA_ASA of a polka dot ICH pattern ahajournals.org/doi/10.1161/…
1
9
674
Interesting result. Great to see Canadian collaboration on this impressive study, including from @UBCmedicine.
Original Article: Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage (SAHARA) nej.md/4ilTVdO @CritCareReviews
1
277
Read #ICOM member Stephen Yip’s recent article “Splice of Life”: How #RNA is Rewriting the #Meningioma Story in #NeuroOncology: buff.ly/41gMrCw
5
16
2,195
Alexander Rebchuk retweeted
Among patients with nonacute subdural hematoma, middle meningeal artery embolization led to a 90-day incidence of symptomatic recurrence or progression similar to that with usual care but with fewer serious adverse events. Full MAGIC-MT trial results: nej.md/3UZm6oM
17
66
14,978